Cleared Traditional

K111642 - ONCO TRAC MODEL 1, 2, 4

K111642 is an FDA 510(k) clearance for ONCO TRAC MODEL 1, manufactured by Translational Sciences Corporation. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 158-day FDA review.

K111642 · Translational Sciences Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2011
Decision
158d
Days
Class 2
Risk

K111642 is an FDA 510(k) clearance for the ONCO TRAC MODEL 1, 2, 4. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Translational Sciences Corporation (Cambridge, US). The FDA issued a Cleared decision on November 18, 2011 after a review of 158 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Translational Sciences Corporation devices

FDA 510(k) Submission Details - K111642

510(k) Number K111642 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2011
Decision Date November 18, 2011
Days to Decision 158 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
51d slower than avg
Panel avg: 107d · This submission: 158d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1279
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K111642.
MOBILE MIM
K112930 · Mim Software, Inc. · Dec 2011
5MP MONOCHROME LCD MONITOR, RADIFORCE GX530
K112354 · Eizo Nanao Corporation · Nov 2011
MW100 (MAMMOGRAPHY) LCD MONITOR SYSTEM
K110596 · Wide Corporation · Nov 2011
VITREA CT MYOCARDIAL ANALYSIS
K112531 · Vital Images, Inc. · Nov 2011
SYNGO VIA MI WORKFLOWS
K113029 · Siemens Medical Solutions USA, Inc. · Nov 2011
MONOCHROME DIGITAL MAMMOGRAPHY LCD MONITOR MS33I2
K112145 · Totoku Electric Co., Ltd. · Nov 2011